NEW YORK (GenomeWeb News) — PerkinElmer has closed its acquisition of Euroscreen Products and Evotec Technologies, the company said Wednesday.
PerkinElmer paid $30.5 million for Evotec, a German company that makes and sells tools for high-throughput and high-content cell and biochemical screening.
The company did not disclose the purchase price for the Belgium-based Euroscreen, which provides GPCR membranes, cell lines, and an aequorin-based cellular assay to drug makers.
PerkinElmer said ongoing revenue for the combined companies in 2006 was around $25 million, and said the acquisitions should be “neutral to slightly accretive” for its 2007 earnings per share.
On Jan. 2 PerkinElmer said it bought the thermal-analysis product line from the British company Triton Technologies.